Amadeus Capital Partners is an investor backing trailblazers solving hard problems across intelligence, human, and planet technology areas from seed to growth stages.
The Series A round was led by Amadeus Capital Partners and S28 Capital to support product development and growth.
"While the pandemic has accelerated this adoption, most Restaurant PerformanceOps rely on experience instead of augmenting that with forecasting using learning models and relevant data. Consequently, the restaurant industry is one of the biggest contributors to food waste. Tenzo’s innovative solution leverages the power of AI using the most appropriate data sources and pertinent models. The PerformanceOps product enables restaurants of all sizes to optimise their operations and reduce food waste, making them more sustainable and profitable."
Molten Ventures led the Series B round with participation from Altair and existing investors to accelerate the development of Deltaflow.OS.
"Solving quantum error correction – one of the defining scientific challenges of our times – will enable quantum computers to accurately simulate the true complexity of nature. Armed with useful quantum computers, humans will enter the Quantum Age, where we go from slow trial and error to solve complex problems to an era of rapid design using quantum computers. We haven’t even begun to imagine the many ways such technology will positively transform our world."
Beringea led the growth round for the patient review platform, with continued support from Keen Venture Partners, Amadeus Capital Partners, and Guinness Ventures.
"Our health is the most precious thing we have. With Doctify, we are working on building the world’s most important healthcare platform to help millions of patients. We are excited to welcome our new investors, Beringea, whom we first met years ago, and we are delighted with the support of our existing investors."
The financing was co-led by Radical Ventures and Temasek to fuel expansion in the United States.
"The next generation of software won’t run on code, it will run on models fueled by training data. We let our clients easily turn human knowledge into AI models, improving the safety and accuracy of AI. This is incredibly powerful, and in the right hands, can literally save lives. If we want to build software that tackles unsolved frontiers in human health, or our climate, this is the only way"
Amadeus Capital Partners and Octopus Ventures co-led the seed round to support product development and team expansion.
"The entire team is very excited about the opportunity that this financing has given us to develop Unlikely AI and its technology, and we are delighted to partner with our new investors."
